Helicore
Pioneering long-acting antibody conjugates to deliver quarterly administered, best-in-category therapies for obesity and cardiometabolic disease.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredOct 17, 2002 (24 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
JL
Jing Liang FounderGK
Gerrit Klaerner Chief Executive Officer & PresidentKB
Kalpesh Biyani Vice President, Drug ProductPK
Paul Kierstead Vice President, Drug Substance
Investors
Companies like Helicore
PPersist AI$12M Series A · May 2025
VVerdiva Bio$410M Series A · Jan 2025
OOna Therapeutics$86.6M Series B+ · Oct 2026
WWander$50M Series B+ · May 2025
AAdcytherixSeries A · Oct 2025
RRevier Therapeutics$6.95M Seed · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/helicore (get a free API key).